Skip to main content
Clinical Trials/NCT00217217
NCT00217217TerminatedPhase 3

Low Field Magnetic Stimulation in Bipolar Depression

Mclean Hospital1 site in 1 country13 target enrollmentStarted: September 1, 2004Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Terminated
Enrollment
13
Locations
1
Primary Endpoint
Positive and Negative Affect Scale

Study Overview

Brief Summary

Individuals with bipolar depression who had a particular kind of brain imaging reported improved mood after the imaging. This effect may be linked to the changing magnetic fields used during these magnetic resonance imaging studies. The current studies are designed to further explore the important parameters of this effect and to clarify the degree and duration of the mood effects.

Detailed Description

An initial study using proton echo-planar magnetic resonance spectroscopic imaging (EP-MRSI) in bipolar depressed individuals was associated with reports of improved mood. These studies employed oscillating magnetic fields similar to those used in functional MRI (fMRI), but which differ from the usual fMRI scan in field direction, waveform frequency, and strength. As the abbreviation EP-MRSI is used to describe several relatively common MR sequences, the specific potential clinical procedure being used is referred to as low field magnetic stimulation or LFMS. Following these initial results, investigators are conducting studies to determine the critical variables in both subjects and treatment for optimal response. Studies are also underway to characterize the response of specific depression symptoms, the degree of response, and the duration of response.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Primary diagnosis of bipolar disorder.
  • •Current depression.

Exclusion Criteria

  • •Contraindication for MRI due to metal in eyes/head
  • •Claustrophobia.
  • •Inability to lie flat.
  • •History of brain injury.

Arms & Interventions

Active EEP-MRSI treatment

Experimental

20 minutes of active treatment with theEcho-Planar Magnetic Resonance Imaging (EP-MRSI)

Intervention: Echo-Planar Magnetic Resonance Imaging (EP-MRSI) (Device)

Sham comparator EP-MRSI

Sham Comparator

Sham treatment (20 minutes) with the Echo-Planar Magnetic Resonance Imaging (EP-MRSI).

Intervention: Echo-Planar Magnetic Resonance Imaging (EP-MRSI) (Device)

Outcomes

Primary Outcomes

Positive and Negative Affect Scale

Time Frame: pre/post-treatment

Secondary Outcomes

  • Visual-Analog Scales(pre/post-treatment)
  • Montgomery Asberg Depression Rating Scale (MADRS)(pre-treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Rohan

Imaging Physicist

Mclean Hospital

Study Sites (1)

Loading locations...

Similar Trials